Document Detail


Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection.
MedLine Citation:
PMID:  20729141     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Risk assessment of parvovirus B19 (B19)-associated fetal complications following gestational B19 infection remains controversial.
OBJECTIVES: To determine the risk of fetal hydrops or non-hydropic late intrauterine fetal death following acute maternal B19 infection at defined gestational weeks.
STUDY DESIGN: Observational cohort study of pregnant women with serologic evidence of acute B19 infection. If available, fetal or neonatal tissue samples from cases complicated by fetal loss or hydrops were investigated for the presence of B19 DNA by polymerase chain reaction (PCR) and/or in situ hybridization (ISH).
RESULTS: Of 236 women with known pregnancy outcome, 228 had a live birth and 8 a fetal loss. The observed rate of fetal hydrops for all pregnant women was 4.2% (10/236) (95% confidence interval [CI], 2.1-7.7) and 10.6% (10/94) (95% CI, 5.2-18.7) for those infected between 9 and 20 weeks gestation. Tissue samples from 8 hydrops cases were investigated by PCR or ISH and all were B19 DNA positive. Fetal death occurring during or after gestational week 22 was only observed in one case which was associated with B19-derived fetal hydrops.
CONCLUSIONS: Our findings demonstrate that although adverse fetal outcome is a rare complication of gestational B19 infection, a relevant risk of fetal hydrops exists particularly for women infected between 9 and 20 weeks' gestation. Cases of B19-derived non-hydropic late intrauterine fetal death were not observed in the present study.
Authors:
Martin Enders; Karin Klingel; Andrea Weidner; Carola Baisch; Reinhard Kandolf; Gunnar Schalasta; Gisela Enders
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-21
Journal Detail:
Title:  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology     Volume:  49     ISSN:  1873-5967     ISO Abbreviation:  J. Clin. Virol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-11     Completed Date:  2011-01-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815671     Medline TA:  J Clin Virol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  163-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier B.V. All rights reserved.
Affiliation:
Laboratory Prof G. Enders and Partners & Institute of Virology, Infectious Diseases and Epidemiology e.V., Rosenbergstrasse 85, D-70193 Stuttgart, Germany. menders@labor-enders.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antibodies, Viral / blood
Cohort Studies
DNA, Viral / genetics,  isolation & purification
Female
Humans
Hydrops Fetalis / epidemiology*,  virology*
Infant, Newborn
Nucleic Acid Hybridization
Parvoviridae Infections / epidemiology*,  mortality
Parvovirus B19, Human / isolation & purification*
Polymerase Chain Reaction
Pregnancy
Pregnancy Complications, Infectious / epidemiology*,  virology
Risk Assessment*
Chemical
Reg. No./Substance:
0/Antibodies, Viral; 0/DNA, Viral

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical features of echovirus 6 and 9 infections in children.
Next Document:  Use of antisera directed against dsRNA to detect viral infections in formalin-fixed paraffin-embedde...